Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
IDEAYA Biosciences, Inc. (IDYA) had Stock-Based Compensation of $10.24M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-72.18M |
|
-- |
|
-- |
|
$84.39M |
|
$-84.39M |
|
$12.21M |
|
$-72.18M |
|
$-72.18M |
|
$-72.18M |
|
$-72.18M |
|
$-72.18M |
|
$-72.18M |
|
$-84.39M |
|
$-87.03M |
|
88.36M |
|
88.36M |
|
$-0.82 |
|
$-0.82 |
|
| Balance Sheet Financials | |
$707.87M |
|
$8.87M |
|
$392.77M |
|
$1.10B |
|
$50.85M |
|
-- |
|
$25.66M |
|
$76.51M |
|
$1.02B |
|
$1.02B |
|
$1.02B |
|
87.56M |
|
| Cash Flow Statement Financials | |
$-60.34M |
|
$79.82M |
|
$26.14M |
|
$85.18M |
|
$130.80M |
|
$45.62M |
|
|
Stock-Based Compensation |
$10.24M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.92 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-61.67M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.05% |
|
-7.05% |
|
-6.56% |
|
-7.05% |
|
$11.70 |
|
$-0.70 |
|
$-0.68 |
|